The United Laboratories International Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares The United Laboratories International Holdings Limited with three other
companies in this sector in Hong Kong:
CSPC Pharmaceutical Group Ltd
sales of 11.39 billion Hong Kong Dollars [US$1.47 billion]
of which 68%
was Finished Drugs),
CK Life Sciences Int'l (Holdings) Incorporated
(4.92 billion Hong Kong Dollars [US$634.10 million]
of which 57%
was Health), and
China Traditional Chinese Medicine Holdings Co Ltd
(4.57 billion Hong Kong Dollars [US$589.45 million]
of which 32%
was Tongjitang Pharmaceutical).
The United Laboratories International Holdings Limited reported sales of HK$7.69 billion (US$991.83 million)
December of 2015.
decrease of 4.2%
versus 2014, when the company's sales were HK$8.03 billion.
Contributing to the drop in overall sales was the 17.0% decline
in Bulk Medicine, from HK$3.94 billion to HK$3.27 billion.
However, these declines were partially offset by the increase in sales of
Finished Products (up 0.4% to HK$2.74 billion)
Intermediate Products (up 23.8% to HK$1.68 billion)